Skip to main content
 
  • NEWS
  • CLINICAL TRIALS
  • INVESTORS
  • CAREERS
  • (ENG) 
    Current country and language options:
    Canada English (ENG)
    • Austria Deutsch
    • Belgium Nederlands Français
    • Brazil Português
    • Canada Français English
    • Czech Republic Čeština
    • Denmark Dansk
    • France Français
    • Germany Deutsch
    • Ireland English
    • Italy Italiano
    • Japan Japanese
    • Luxembourg Français Deutsch
    • Netherlands Nederlands
    • Portugal Português
    • Spain Español
    • Sweden Svenska
    • Switzerland Français Deutsch Italiano
    • Taiwan Traditional Chinese
    • United Kingdom English
    • Global English
     
 
 
Logo Logo Logo
  • About
    Alnylam
  • Our
    Science
  • Our
    Pipeline
  • Our
    Products
  • News
  • Contact Us
  • About Alnylam
  • Our Science
  • Our Pipeline
  • Our Products
  • News
  • Contact Us
OUR PRODUCTS

Approved in Canada

ONPATTRO® (patisiran)
 
onpattro logo

PDF icon

Click here to view Product Monograph ›

PDF icon

Cliquez ici pour le monographie de produit ›

 
 
 
GIVLAARI™ (givosiran)
 
onpattro logo

PDF icon

Click here to view Product Monograph ›

PDF icon

Cliquez ici pour le monographie de produit ›

 
 
 
OXLUMO™ (lumasiran)
 
logo-oxlumo

PDF icon

Click here to view Product Monograph ›

PDF icon

Cliquez ici pour le monographie de produit ›

 
 

This website is intended for residents of Canada only.

Corp-CAN-00009 May 2022

Privacy Policy Legal Notice
Copyright © 2022 Alnylam Pharmaceuticals, Inc. — All Rights Reserved

YOU ARE NOW BEING REDIRECTED

You are now leaving www.alnylam.ca and going to our global website (www.alnylam.com), which is in English.

Continue ›